WEKO3
アイテム
{"_buckets": {"deposit": "152ba0d9-bcd2-4511-852c-9cdc7e06ffc1"}, "_deposit": {"created_by": 1, "id": "46094", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "46094"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00046094", "sets": ["1"]}, "author_link": ["458893", "458888", "458887", "458892", "458896", "458894", "458890", "458891", "458889", "458886", "458895"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2010-07", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "10", "bibliographicPageEnd": "1786", "bibliographicPageStart": "1778", "bibliographicVolumeNumber": "18", "bibliographic_titles": [{"bibliographic_title": "Molecular Therapy"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Glioblastoma multiforme (GM), the most frequent primary malignant brain tumor, is highly invasive due to the expression of proteases, including urokinase-type plasminogen activator (uPA). Here, we show the potential of our new and powerful recombinant Sendai virus (rSeV) showing uPA-specific cell-to-cell fusion activity [rSeV/dMFct14 (uPA2), named \"BioKnife\"] for GM treatment, an effect that was synergistically enhanced by arming BioKnife with the interferon-beta (IFN-beta) gene. BioKnife killed human GM cell lines efficiently in a uPA-dependent fashion, and this killing was prevented by PA inhibitor-1. Rat gliosarcoma 9L cells expressing both uPA and its functional receptor uPAR (9L-L/R) exhibited high uPA activity on the cellular surface and were highly susceptible to BioKnife. Although parent 9L cells (9L-P) were resistant to BioKnife and to BioKnife expressing IFN-beta (BioKnife-IFNbeta), cell-cell fusion of 9L-L/R strongly facilitated the expression of IFN-beta, and in turn, IFN-beta significantly accelerated the fusion activity of BioKnife. A similar synergy was seen in a rat orthotopic brain GM model with 9L-L/R in vivo; therefore, these results suggest that BioKnife-IFNbeta may have significant potential to improve the survival of GM patients in a clinical setting.", "subitem_description_type": "Abstract"}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1038/mt.2010.138", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1525-0016", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Hasegawa, Yuzo"}], "nameIdentifiers": [{"nameIdentifier": "458886", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iwadate, Yasuo"}], "nameIdentifiers": [{"nameIdentifier": "458887", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Saito, Shigeyoshi"}], "nameIdentifiers": [{"nameIdentifier": "458888", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aoki, Ichio"}], "nameIdentifiers": [{"nameIdentifier": "458889", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Saeki, Naokatsu"}], "nameIdentifiers": [{"nameIdentifier": "458890", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yonemitsu, Yoshikazu"}], "nameIdentifiers": [{"nameIdentifier": "458891", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "458892", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "長谷川 祐三", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "458893", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岩立 康男", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "458894", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "齋藤 茂芳", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "458895", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "青木 伊知男", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "458896", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-beta gene", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-beta gene"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/46094", "pubdate": {"attribute_name": "公開日", "attribute_value": "2011-06-06"}, "publish_date": "2011-06-06", "publish_status": "0", "recid": "46094", "relation": {}, "relation_version_is_last": true, "title": ["Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-beta gene"], "weko_shared_id": -1}
Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-beta gene
https://repo.qst.go.jp/records/46094
https://repo.qst.go.jp/records/4609435f8b508-5c8d-47e5-b916-963a8fcad548
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2011-06-06 | |||||
タイトル | ||||||
タイトル | Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-beta gene | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Hasegawa, Yuzo
× Hasegawa, Yuzo× Iwadate, Yasuo× Saito, Shigeyoshi× Aoki, Ichio× Saeki, Naokatsu× Yonemitsu, Yoshikazu× et.al× 長谷川 祐三× 岩立 康男× 齋藤 茂芳× 青木 伊知男 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Glioblastoma multiforme (GM), the most frequent primary malignant brain tumor, is highly invasive due to the expression of proteases, including urokinase-type plasminogen activator (uPA). Here, we show the potential of our new and powerful recombinant Sendai virus (rSeV) showing uPA-specific cell-to-cell fusion activity [rSeV/dMFct14 (uPA2), named "BioKnife"] for GM treatment, an effect that was synergistically enhanced by arming BioKnife with the interferon-beta (IFN-beta) gene. BioKnife killed human GM cell lines efficiently in a uPA-dependent fashion, and this killing was prevented by PA inhibitor-1. Rat gliosarcoma 9L cells expressing both uPA and its functional receptor uPAR (9L-L/R) exhibited high uPA activity on the cellular surface and were highly susceptible to BioKnife. Although parent 9L cells (9L-P) were resistant to BioKnife and to BioKnife expressing IFN-beta (BioKnife-IFNbeta), cell-cell fusion of 9L-L/R strongly facilitated the expression of IFN-beta, and in turn, IFN-beta significantly accelerated the fusion activity of BioKnife. A similar synergy was seen in a rat orthotopic brain GM model with 9L-L/R in vivo; therefore, these results suggest that BioKnife-IFNbeta may have significant potential to improve the survival of GM patients in a clinical setting. | |||||
書誌情報 |
Molecular Therapy 巻 18, 号 10, p. 1778-1786, 発行日 2010-07 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1525-0016 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1038/mt.2010.138 |